Outset Medical, Inc.

OM Healthcare Medical Devices

Outset Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $119.5 million, up 5.09% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 6.73%, free cash flow fell 90.5% and total debt rose 4.20%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

3.94 0.14 −3.43%
Market cap
$76.6M
P/E
0.0×
Fwd P/E
−1.1×
Dividend yield
—
F-score
6/9
Altman Z
−5.37
Beneish M
−3.25
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — 5 3 3 5 6
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — — 5.79 12.44 2.01 (3.92) (5.41) (5.37)
P/S ratio
— 0.00 0.00 18.63 20.49 10.40 2.14 0.51 0.47
Altman Z″-Score (non-manufacturers)
— — (14.26) 3.67 3.17 (2.18) (8.02) (10.47) (9.87)
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Beneish M-Score
— — — — (3.18) (3.50) (3.25) (3.00) (3.25)
P/Operating CF
— (18.32) (18.32) (36.00) (64.34) (34.77) (11.44) (3.50) (5.93)
P/B ratio
— 0.00 0.00 2.83 5.62 4.88 2.28 2.15 0.44
EV/Sales
— 0.00 0.00 12.94 17.48 8.75 1.59 0.86 (0.13)
EV/EBITDA
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.24
EV/FCF
— (2.00) (2.00) (5.98) (13.45) (6.55) (1.54) (0.83) 0.32
Current Ratio
— 14.46 3.20 9.43 7.93 7.19 5.26 5.69 6.67
Net Debt/EBITDA
— 2.46 0.59 2.50 2.51 1.23 0.43 (0.34) 1.13
Debt/Equity
— 0.00 0.78 0.09 0.08 0.39 1.06 7.36 0.76
ROE
— 22.14% 25.89% 364.06% (37.55%) (52.56%) (93.69%) (170.97%) (106.20%)
ROA
— 0.00% (193.43%) (32.23%) (30.42%) (37.74%) (48.41%) (43.41%) (30.23%)
ROIC
— 0.00% 0.00% (169.11%) (126.76%) (183.56%) (213.60%) (108.17%) (76.86%)
Return on Tangible Assets
— (52.07%) (136.45%) (24.47%) (35.56%) (48.27%) (69.35%) (57.91%) (37.47%)
Average Days of Receivables
— 197.87 94.75 47.28 91.07 88.80 92.33 114.36 86.55
Earnings Yield
— (31.41%) (31.41%) (23.70%) (6.25%) (13.69%) (62.02%) (223.31%) (183.02%)
Free Cash Flow Yield
— (34.92%) (34.92%) (11.62%) (6.34%) (12.84%) (48.22%) (203.29%) (83.51%)
Free Cash Flow per Share
— (996.03) (1,286.45) (99.07) (43.86) (47.96) (40.79) (33.85) (3.10)
Book value per Share
— 0.00 651.38 301.17 123.02 76.58 37.18 7.74 8.35
Free Cash Flow
— (48.21) (73.58) (108.09) (133.37) (154.05) (134.81) (117.21) (47.12)
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.23
Other line items

Show all line items

Columns are period end dates